Arthrosi Therapeutics
PrivateLast Round
Series E
Oct 8, 2025
Est. Valuation
$800M
Total Funding Raised
$283.14M
Company Overview
Arthrosi Therapeutics, Inc. is a clinical-stage biotechnology company developing therapeutics for gout and chronic kidney disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arthrosi Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Arthrosi Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Oct 8, 2025 | ||||
| Seed Round | Jan 26, 2024 | ||||
| Series D | Jul 11, 2023 | ||||
| VC Round | Mar 3, 2023 | ||||
| Series C Extension | Aug 17, 2021 | ||||
Series C | Oct 23, 2020 |
Arthrosi Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series E |
| Highlight Capital | Series E |
| HM Venture Partners | Series E |
| Viva BioInnovator | Seed |
| Viva Biotech | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2025
$153M round raised at $800M post-money valuation.
- Jan 26, 2024
$7M round raised
Arthrosi Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arthrosi Therapeutics's valuation, stock price, and market status.
